Comparative Formulation Study of Vabicaserin

NCT00928551 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Subjects

Interventions

DRUG: vabicaserin

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer